Literature DB >> 7908219

Increased frequency of the S allele of the L-myc oncogene in non-Hodgkin's lymphoma.

P E Crossen1, M J Morrison, B M Colls.   

Abstract

We studied 100 patients with non-Hodgkin's lymphoma, 44 patients with Hodgkin's disease and 100 controls for the prevalence of the EcoRI restriction fragment polymorphism of the L-myc oncogene. No difference in the frequency of the three genotypes (LL, LS, SS) was found between the patient and control groups. However, the S allele was found to occur more frequently in the non-Hodgkin's lymphoma patients (chi 2 = 4.57, P = 0.032). These data confirm an earlier report and suggest that the presence of the S allele is associated with susceptibility to non-Hodgkin's lymphoma.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7908219      PMCID: PMC1968797          DOI: 10.1038/bjc.1994.143

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  16 in total

1.  Unique allelic restriction fragments of the human Ha-ras locus in leukocyte and tumour DNAs of cancer patients.

Authors:  T G Krontiris; N A DiMartino; M Colb; D R Parkinson
Journal:  Nature       Date:  1985 Jan 31-Feb 6       Impact factor: 49.962

2.  A simple method for DNA purification from peripheral blood.

Authors:  T A Ciulla; R M Sklar; S L Hauser
Journal:  Anal Biochem       Date:  1988-11-01       Impact factor: 3.365

3.  A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity.

Authors:  A P Feinberg; B Vogelstein
Journal:  Anal Biochem       Date:  1983-07-01       Impact factor: 3.365

4.  Restriction fragment length polymorphism of the L-myc gene and susceptibility to metastasis in renal cancer patients.

Authors:  Y Kakehi; O Yoshida
Journal:  Int J Cancer       Date:  1989-03-15       Impact factor: 7.396

5.  Correlation of L-myc RFLP with metastasis, prognosis and multiple cancer in lung-cancer patients.

Authors:  K Kawashima; S Nomura; H Hirai; S Fukushi; T Karube; K Takeuchi; T Naruke; S Nishimura
Journal:  Int J Cancer       Date:  1992-02-20       Impact factor: 7.396

6.  Close correlation between restriction fragment length polymorphism of the L-MYC gene and metastasis of human lung cancer to the lymph nodes and other organs.

Authors:  K Kawashima; H Shikama; K Imoto; M Izawa; T Naruke; K Okabayashi; S Nishimura
Journal:  Proc Natl Acad Sci U S A       Date:  1988-04       Impact factor: 11.205

7.  L-myc, a new myc-related gene amplified and expressed in human small cell lung cancer.

Authors:  M M Nau; B J Brooks; J Battey; E Sausville; A F Gazdar; I R Kirsch; O W McBride; V Bertness; G F Hollis; J D Minna
Journal:  Nature       Date:  1985 Nov 7-13       Impact factor: 49.962

8.  Presence of an allelic EcoRI restriction fragment of the c-mos locus in leukocyte and tumor cell DNAs of breast cancer patients.

Authors:  R Lidereau; D Mathieu-Mahul; C Theillet; M Renaud; M Mauchauffé; J Gest; C J Larsen
Journal:  Proc Natl Acad Sci U S A       Date:  1985-10       Impact factor: 11.205

9.  Restriction fragment length polymorphisms of L-myc and myb in human leukaemia and lymphoma in relation to age-selected controls.

Authors:  G Chenevix-Trench; M Southall; C Kidson
Journal:  Br J Cancer       Date:  1989-12       Impact factor: 7.640

10.  Genetic predisposition to human lung cancer.

Authors:  J Heighway; N Thatcher; T Cerny; P S Hasleton
Journal:  Br J Cancer       Date:  1986-04       Impact factor: 7.640

View more
  3 in total

Review 1.  Limited-stage small cell lung cancer: current chemoradiotherapy treatment paradigms.

Authors:  Thomas E Stinchcombe; Elizabeth M Gore
Journal:  Oncologist       Date:  2010-02-09

2.  MYCL genotypes and loss of heterozygosity in non-small-cell lung cancer.

Authors:  K M Fong; Y Kida; P V Zimmerman; P J Smith
Journal:  Br J Cancer       Date:  1996-12       Impact factor: 7.640

3.  Different susceptibility of each L-myc genotype to esophageal cancer risk factors.

Authors:  H Kumimoto; N Hamajima; K Nishizawa; Y Nishimoto; K Matsuo; H Harada; M Shinoda; S Hatooka; K Ishizaki
Journal:  Jpn J Cancer Res       Date:  2001-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.